Secondary sclerosing cholangitis following major burn injury - An underestimated issue in burn care?

Burns

Volumn 37, Issue 2, 2011, Pages 355-356

  Ipaktchi, R ^a   Knobloch, K ^a   Vogt, P M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; URSODEOXYCHOLIC ACID; VASOCONSTRICTOR AGENT;

ANTIBIOTIC THERAPY; BURN; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; ENTEROCOCCAL INFECTION; HOSPITAL INFECTION; HUMAN; LETTER; LOW DRUG DOSE; PATHOGENESIS; SCLEROSING CHOLANGITIS; SECONDARY SCLEROSING CHOLANGITIS; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; BURNS; CHOLANGITIS, SCLEROSING; CRITICAL ILLNESS; HUMANS; URSODEOXYCHOLIC ACID;

EID: 79551601456     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2010.06.014     Document Type: Letter

References (5)

1. S. Al-Benna, J. Willert, H.U. Steinau, and L. Steinstraesser Secondary sclerosing cholangitis, following major burn injury Burns 36 2010 e106 e110
2. R. Abdalian, and E.J. Heathcote Sclerosing cholangitis: a focus on secondary causes Hepatology 44 2006 1063 1074
3. P. Ruemmele, F. Hofstaedter, and C.M. Gelbmann Secondary sclerosing cholangitis Nat Rev Gastroenterol Hepatol 6 2009 287 295
4. B. Hoffmeister, J. Ockenga, G. Schachschal, N. Suttorp, and J. Seybold Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci J Infect 54 2007 e65 e68
5. R.W. Chapman Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC? Nat Rev Gastroenterol Hepatol 7 2010 74 75